Markets:

Overview

News

Currencies

International

Treasuries

Zimmer Holdings (NY:ZBH)

92.42 -2.33 (-2.45%)

Streaming Delayed Price Updated: 12:33 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Zimmer Holdings

Bragar Eagel & Squire, P.C. Is Investigating Gauzy and Zimmer Biomet and Encourages Investors to Contact the Firm

November 20, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Zimmer Biomet Holdings, Inc. (ZBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

November 13, 2025

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

November 13, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

November 12, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery

July 29, 2025

From Monogram Technologies Inc.

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Monogram Technologies Inc. (Nasdaq - MGRM), Veritex Holdings, Inc. (Nasdaq - VBTX), ESSA Pharma Inc. (Nasdaq - EPIX), Waters Corporation (NYSE - WAT)

July 14, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions

July 14, 2025

From Monogram Technologies Inc.

Via GlobeNewswire

Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology

June 05, 2025

From Treace Medical Concepts, Inc.

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Accolade, Inc. (Nasdaq - ACCD), Paragon 28, Inc. (NYSE - FNA), Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN)

February 19, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Boston Scientific: Why This MedTech Giant Isn’t Slowing Down

September 17, 2024

Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs.

Via MarketBeat

Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?

August 14, 2024

Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia

Via MarketBeat

Medical Technology Stock Benefits from Rising Acute Care Demand

August 07, 2024

Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry.

Via MarketBeat

Topics Supply Chain

Why Intuitive Surgical Stock is Dominating the Medical Sector

August 06, 2024

Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However

Via MarketBeat

Intuitive Surgical Leads the Robotic Surgery Movement

April 22, 2024

Intuitive Surgical is the pioneer in robotic-assisted surgery, investors hope the fifth generation of its da Vinci system can push ISRG stock higher

Via MarketBeat

Topics Artificial Intelligence

Hidden gems: 3 undervalued stocks with a unique competitive edge

January 05, 2024

Etsy, International Flavors & Fragrances and Zimmer Biomet are undervalued stocks with unique market advantages. Patient investors may find opportunities here.

Via MarketBeat

Is the Ozempic-Driven DexCom Selloff Overdone?

October 18, 2023

Has glucose monitor maker DexCom corrected too much on fears of lost sales due to weight loss and diabetes drugs made by Novo Nordisk and Eli Lilly?

Via MarketBeat

3 Undervalued Healthcare Stocks to Watch as Sector Struggles

October 06, 2023

As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth.

Via MarketBeat

DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth

June 21, 2023

DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next.

Via MarketBeat

Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand

June 16, 2023

Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers.

Via MarketBeat

Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher

April 12, 2023

Shockwave got a 10.64% jolt on a proposed Medicare change that could up the usage of its gear. Other medical product makers are forming bullish consolidations.

Via MarketBeat

Zimmer Biomet Beats on Earnings, Growth May be Priced In

February 03, 2023

Zimmer Biomet stock is gaining after beating expectations. However, ZBH stock was fairly valued before earnings meaning investors may need to wait on analysts

Via MarketBeat

Is Zimmer Biomet a Buy Ahead of Earnings?

January 31, 2023

Zimmer will report Q4'22 earnings this week. The question on people's minds is if it's a buy prior to this announcement being made.

Via MarketBeat

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.